Drug Patent Expirations in March 2011

Drug Patent Expirations in March 2011

*Drugs may be covered by multiple patents

Tradename Applicant Generic Name Patent Number Patent Expiration
AZOPT Alcon brinzolamide 5,240,923*PED Mar 1, 2011
SYMLIN Amylin pramlintide acetate 6,610,824 Mar 3, 2011
NITROLINGUAL PUMPSPRAY Pohl Boskamp nitroglycerin 5,186,925 Mar 6, 2011
SYMLIN Amylin pramlintide acetate 6,610,824 Mar 8, 2011
SYMLIN Amylin pramlintide acetate 7,407,934 Mar 8, 2011
SYMLIN Amylin pramlintide acetate 5,998,367 Mar 8, 2011
VANTAS Endo Pharm histrelin acetate 5,292,515 Mar 8, 2011
SUPPRELIN LA Endo Pharm histrelin acetate 5,292,515 Mar 8, 2011
SYMLIN Amylin pramlintide acetate 7,271,238 Mar 8, 2011
FOLLISTIM Organon Usa Inc follitropin alfa/beta 5,270,057 Mar 20, 2011
PROSCAR Merck finasteride 6,046,183 Mar 20, 2011
FAMVIR Novartis famciclovir 5,246,937*PED Mar 21, 2011
XALATAN Pharmacia And Upjohn latanoprost 5,422,368 Mar 22, 2011
XALATAN Pharmacia And Upjohn latanoprost 5,296,504 Mar 22, 2011
ENTEREG Adolor alvimopan 5,250,542 Mar 29, 2011

This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin. Courtesy of DrugPatentWatch.com


   2 Comments


  1. Allen Rosenston
      Mar 8, 2011

    I just came across your site and saw the March 2011 Expiration information. I was hoping to get prior months and clicked on the “ARCHIVES” option. All I got was a blank page, no archived data. Is the patent expiration data available for January and February this year and for the last 6 months of 2010?

  2. BiotechBlog
      Mar 9, 2011

    Thanks for the note. I’ve fixed the archives.

Leave a Reply